Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

-

INDMoney rank
8/8
2/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

6 Years 9 Months

7 Years 9 Months

Fund AUM

₹854 Cr

₹6801 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

1.04%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

43

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.34%)
  2. Apollo Hospitals Enterprise Ltd(7.78%)
  3. Torrent Pharmaceuticals Ltd(5.2%)
  4. J.B. Chemicals & Pharmaceuticals Ltd(4.99%)
  5. Ajanta Pharma Ltd(4.53%)
  1. Sun Pharmaceuticals Industries Ltd(11.21%)
  2. Cipla Ltd(9.4%)
  3. Mankind Pharma Ltd(7.64%)
  4. Dr Reddy's Laboratories Ltd(6.52%)
  5. Biocon Ltd(6.2%)
No of Sectors

2

2

Top 3 Sectors
  1. Health(99.17%)
  2. Basic Materials(0.83%)
  1. Health(98.81%)
  2. Basic Materials(1.19%)
Equity %

98.45%

97.98%

Debt %

-

-

P/E

37.59

32.15

P/B

5.63

3.94

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-1.99%

-3.18%

3-Month Return

-1.21%

-7.56%

6-Month Return

-1.96%

-8.02%

1-Year Return

2.38%

-0.03%

3-Year Return

25.24%

27.34%

5-Year Return

15.59%

17.85%

Sharpe

1.15

1.3

Alpha

0.01

2.27

Beta

0.94

0.94

Standard Deviation

15.79

15.86

Information Ratio

-0.35

0.44

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons